Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / *W EXP 09/01/203
-
Total 13F shares
-
2,851,427
-
Share change
-
-49,558
-
Total reported value
-
$2,088,196
-
Price per share
-
$0.71
-
Number of holders
-
30
-
Value change
-
-$35,774
-
Number of buys
-
2
-
Number of sells
-
8
Institutional Holders of Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 (OACCW) as of Q4 2025
As of 31 Dec 2025,
Oaktree Acquisition Corp. III Life Sciences - *W EXP 09/01/203 (OACCW) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,851,427 shares.
The largest 10 holders included
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, AQR Arbitrage LLC, Driehaus Capital Management LLC, Walleye Capital LLC, Boussard & Gavaudan Investment Management LLP, Decagon Asset Management LLP, JPMORGAN CHASE & CO, Linden Advisors LP, Shaolin Capital Management LLC, and BNP PARIBAS FINANCIAL MARKETS.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.